Page URL: https://www.bionews.org.uk/page_94180

Japan's health ministry approves pluripotent stem cell research

28 June 2013
Appeared in BioNews 711

A Japanese Health Ministry panel has approved the first use of induced pluripotent stem cells (iPS cells) in human trials.

The Riken Center for Developmental Biology hopes to use iPS cells to treat age-related macular degeneration (AMD), a common cause of blindness in older people. Its small-scale pilot study would test the safety of iPS cells transplanted into patients' eyes.

The trial still requires final approval from Japan's minister of health, labour and welfare but this is likely later this month. Should approval be granted, the study could start before the end of the year.

'No one on Earth has established basic standards for iPS cell treatments', lead researcher Dr Masayo Takahashi told The Mainichi. 'What we're doing will strongly influence world standards for the technology; we'll be making the rules'.

AMD damages pigment epithelium cells in the eye, causing reduced vision leading to blindness. The pilot study will recruit six patients, all at least 50 years old, who have not responded to conventional treatment.

Researchers will reprogram the patient's own skin cells to become iPS cells and then direct them to become pigment epithelium. Damaged epithelium will be removed from the patients' eyes and replaced with a sheet of these new cells. The research team will closely monitor the patients for any complications for four years after the operation.

As the pilot study will focus on safety, it is unlikely the patients will experience significant improvements in their vision. Kanji Takahashi, chief ophthalmologist at Kansai Medical University Hirokata hospital, told AFP: 'The trial is a hope for AMD patients, but it will probably take years before the new treatment will actually contribute to improving the vision of many people'.

Dr Masayo Takahashi also expects a very modest improvement in sight for the initial trial. 'I'd really like people to temper their expectations', she told The Mainichi.

SOURCES & REFERENCES
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
29 July 2013 - by Dr Greg Ball 
Light-sensitive cells found in the retina have been grown from mouse embryonic stem cells (ESCs) and successfully transplanted into the eyes of visually impaired mice, restoring some vision...
22 July 2013 - by Holly Rogers 
For the first time, scientists have created induced pluripotent stem cells from adult tissue without adding extra genes...
8 July 2013 - by James Brooks 
Stem cells generated from adult cells have been used to grow tiny 'liver buds' which were then successfully transplanted into mice...
24 June 2013 - by Sarah Pritchard 
Researchers in Japan are one step closer to being able to implant human induced pluripotent stem (iPS) cells into an animal embryo. Their aim is to grow a fully-grown human pancreas in an animal, a pig, and ultimately harvest and transplant such organs into patients...
17 June 2013 - by Dr Amina Aitsi-Selmi 
Stem cells in the nail bed may be the key to regenerating amputated fingertips, if a study on mice is anything to go by...
18 February 2013 - by Reuben Harwood 
What would be the first clinical trial to use induced pluripotent stem cells has been granted ethical approval in Japan...
7 January 2013 - by Dr Greg Ball 
Immune cells that can recognise and kill cancer cells have been grown from induced pluripotent stem cells (iPSCs)...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.